Delivery Order SPE2DR25D9246-SPE2DR26FFMP6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,227.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. This firm fixed-price delivery order, awarded on November 4, 2025, with an ultimate completion date of November 26, 2025, represents a routine pharmaceutical supply requirement supporting Department of Defense medical operations. The award carries no...
- The Defense Logistics Agency awarded a $1,113.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) in single-dose vials on October 20, 2025. The delivery order, with an ultimate completion date of November 10, 2025, carries no set-aside designation, allowing the woman-owned small business to compete directly against other qualified vendors. DMS Pharmaceutical Group, headquartered in Park Ridge, Illinois, is the sole awardee with no identified...
- The Defense Logistics Agency awarded a $27,835.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vial format. This $1,113.42 firm fixed-price delivery order was issued on October 29, 2025, with an ultimate completion date of November 20, 2025, and carries no set-aside designation. The award leverages DMS Pharmaceutical Group's position as a regional prime...
- The Defense Logistics Agency awarded a delivery order valued at $16,701.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents one of numerous recent awards issued to DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in an unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, a yellow fever vaccine product. The contract, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, operates under a firm fixed-price structure with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Illinois...
- The Defense Logistics Agency awarded a delivery order valued at $2,783.80 to DMS Pharmaceutical Group Inc. for YF-VAX (Yellow Fever Vaccine) 1 dose vials on October 30, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract with an ultimate completion date of November 21, 2025. This delivery order was issued without a set-aside designation, reflecting the company's competitive...
- The Defense Logistics Agency awarded a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The contract utilizes firm fixed-price pricing with an ultimate completion date of November 13, 2025, and was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials on August 20, 2025. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 11, 2025, with performance taking place in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, will supply the yellow fever vaccine vials to support federal healthcare needs....
- SPE2DR25D9246Indefinite Delivery Contract
- SPE2DR25D9246-SPE2DR26FFMP6Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,783.80 to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) in one-dose vial quantities. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order, issued on November 5, 2025, with an ultimate completion date of November 28, 2025, represents a routine pharmaceutical supply transaction within the company's established federal contracting relationship. This award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceutical products to Department of Defense military healthcare facilities worldwide. The parent IDC, valued at $499,999,999 with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a critical regional pharmaceutical supplier authorized to provide an extensive range of branded and generic prescription drugs, biologics, vaccines, and medical consumables to support recurring DoD medical supply needs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 11/5/25 |